About the Company
Ekso Bionics Holdings Inc. is a company that develops and manufactures powered exoskeleton bionic devices that can be strapped on as wearable robots to enhance the strength, mobility, and endurance of industrial workers and people experiencing paralysis and mobility issues after a brain injury, stroke, multiple sclerosis (MS) or spinal cord injury. They enable individuals with any amount of lower extremity weakness, including those who are paralyzed, to stand up and walk. Ekso Bionics currently focuses in the health and industrial sectors. The company's first commercially available health product was called EksoGT (formerly eLEGS). Ekso Bionics is the original developer of HULC, now under military development by Lockheed Martin, and the current developers of EksoNR, which allows patients who are relearning to walk the ability to stand and take steps. In December 2022, Ekso Bionics acquired the Human Motion & Control business unit from Parker Hannifin which includes the Indego product line. This acquisition allowed Ekso Bionics to begin selling exoskeletons to those who have an SCI and want a personal exoskeleton to walk at home and in their community. This personal exoskeleton is available to eligible Medicare beneficiaries for reimbursement starting in April 2024. Ekso was selected as Wired magazine's number two "Most Significant Gadget of 2010", and was included in Time magazine's "50 Best Innovations of 2010". Ekso Bionics was also featured in Inc. magazine as one of "5 Big Ideas for the Next 15 Years".
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on EKSO BIONICS HOLDINGS, INC.
Ekso Bionics outlines AI-powered rehabilitation push as personal health revenues grow 50% amid temporary enterprise sales delays
Q2 2025 Management View CEO Scott G. Davis opened by addressing the quarter’s performance, stating, "Our second quarter revenues were disappointing. But as Jerome noted, we believe this was a ...
Ekso Bionics Holdings, Inc. (EKSO) Q2 2024 Earnings Call Transcript
Ekso Bionics Holdings, Inc. (NASDAQ: EKSO) Q2 2024 Earnings Conference Call July 29, 2024 4:30 PM ET Company Participants Matt Steinberg - Finn Partners Scott Davis - Chief Executive Officer ...
Ekso Bionics Holdings Inc (EKSO) Q2 2025 Earnings Call Highlights ...
Negative Points Ekso Bionics Holdings Inc (NASDAQ:EKSO) experienced a significant revenue decline in Q2 2025, with revenues dropping to $2.1 million from $5 million in Q2 2024. Gross profit and ...
Ekso Bionics Holdings, Inc. (EKSO) Q4 2023 Earnings Call Transcript
Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Q4 2023 Earnings Conference Call March 4, 2024 4:30 PM ETCompany ParticipantsMatt Steinberg - Finn PartnersScott ...
Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Q4 2024 Earnings Call ...
Earlier today, Ekso Bionics Holdings, Inc. released financial results for the quarter and year ended December 31, 2024. A copy of the press release is available on our website.
EKSO - Ekso Bionics Holdings Inc Key Metrics | Morningstar
Review the current Ekso Bionics Holdings Inc (EKSO:XNAS) growth, profitability and efficiency, financial health, and cash flow key metrics to decide if EKSO is the best investment for you.
Preview: Ekso Bionics Holdings's Earnings
Performance of Ekso Bionics Holdings Shares Shares of Ekso Bionics Holdings were trading at $4.72 as of July 24. Over the last 52-week period, shares are down 78.81%.
Ekso Bionics Holdings Inc. Advanced Charts | EKSO | Barron's
Ekso Bionics Holdings, Inc. engages in the provision of design, development, and sale of exoskeleton technology that currently has applications in healthcare and industrial markets.
Ekso Bionics Holdings Inc. Stock Grades | EKSO | Barron's
Ekso Bionics Holdings, Inc. engages in the provision of design, development, and sale of exoskeleton technology that currently has applications in healthcare and industrial markets.
Interview with the CEO: Ekso Bionics Holdings Inc. (NASDAQ:EKSO)
Prior to joining Ekso Bionics, from December 2018 through March 2021, Mr. Davis served as Chief Executive Officer of Globalmatix, Inc., a disruptive IoT-connected telematics solution provider, and ...
Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Q3 2024 Earnings Call ...
Ekso Bionics Holdings, Inc. misses on earnings expectations. Reported EPS is $-0.10202 EPS, expectations were $-0.08. Operator: Greetings, and welcome to the Ekso Bionics Quarter Three 2024 ...
Similar Companies
| Company | Ticker | 90 Days Forecast | Market Cap. (USD M) | P/E | P/B |
|---|---|---|---|---|---|
| EKSO BIONICS HOLDINGS, INC. | EKSO | Predict | 110.36 | -0.93 | 8.70 |
| ESAB Corp | ESAB | Predict | 6899.34 | 26.93 | 3.33 |
| Hongli Group Inc. | HLP | Predict | 8.99 | None | 0.43 |
| Nauticus Robotics, Inc. | KITT | Predict | 42.92 | -0.20 | 28.21 |
| Nauticus Robotics, Inc. | KITTW | Predict | 0.44 | None | -0.01 |
| NORDSON CORP | NDSN | Predict | 12222.64 | 27.37 | 4.13 |
| Ouster, Inc. | OUST | Predict | 1821.87 | -4.20 | 8.24 |
| Ouster, Inc. | OUSTW | Predict | 2.22 | None | 0.01 |
| Ouster, Inc. | OUSTZ | Predict | 4.98 | None | 0.03 |
| RICHTECH ROBOTICS INC. | RR | Predict | 211.60 | None | 4.24 |
| REGAL REXNORD CORP | RRX | Predict | 10099.59 | 68.22 | 1.57 |
| Serve Robotics Inc. /DE/ | SERV | Predict | 576.13 | 83.49 | 2.78 |
| Symbotic Inc. | SYM | Predict | 15633.52 | -162.56 | 79.26 |
| TAYLOR DEVICES, INC. | TAYD | Predict | 187.15 | 11.97 | 3.47 |
Loading the latest forecasts...